MAPT and Alzheimer disease: Interestingly, AT270, an antibody that recognizes p-tau181, has been shown to stain fewer NFTs and neuropil threads in brain tissue from AD patients than AT10036, indicating that CSF p-tau217 might better reflect the pathological state of tau associated with PHF-tau formation.